Background Since the mid-1980s, Professor Grammont's design and promotion of reverse shoulder arthroplasty (RSA) has initiated a new area in shoulder joint surgery. Following the FDA approval of RSA in the United States in 2003, its adoption has experienced explosive growth, and RSA has now become an indispensable option for treating various shoulder pathologies. Although initially developed for cuff tear arthropathy (CTA) due to the inability of conventional shoulder arthroplasty to effectively restore stability and function in such cases, its clinical success has expanded its applications to other shoulder conditions. These include massive rotator cuff tears (MRCT) , glenohumeral arthritis with intact rotator cuff, acute proximal humeral fractures, sequelae of proximal humeral fractures, proximal humeral tumors, inflammatory arthropathies, and revision surgeries following failed anatomic total shoulder arthroplasty or hemiarthroplasty. With the increasing utilization of RSA, complication rates have concurrently risen, reported to range between 15%-50%. However, given that RSA is frequently employed for clinically challenging conditions—many representing salvage procedures—the relatively high complication rates are not unexpected. Significant variations in reported complication rates exist across studies due to differing definitions of complications and prosthesis heterogeneity. Improvements in RSA concepts, designs, and surgical techniques have led to evolving complication profiles. For instance, early prosthesis designs were associated with higher rates of scapular notching, while contemporary designs have substantially reduced this complication. Consequently, modern prostheses and surgical techniques demonstrate significantly lower revision rates than earlier generations. Therefore, monitoring complication patterns and incidence remains crucial as RSA indications continue to expand and surgical techniques progress. Compared to international experience, RSA adoption in China began later, with limited complication-related research reported. Exceptionally constrained by single-center case volumes, there remains a paucity of domestic studies analyzing complications in cohorts exceeding 100 cases, highlighting the necessity for further investigation in this field.
Objective To analyze and explore the occurrence of single-center reverse shoulder arthroplasty complications in China.
Methods A review was conducted on 164 cases of RSA performed by a single surgeon in our hospital. The average age of the patients was (70.2±7.98) years (ranging from 24 to 85 years) , and the average follow-up period was 18.6 months (ranging from 1 to 96 months) . The incidence of surgery-related complications was evaluated.
Results There were a total of 25 cases of total complications, with an incidence rate of (15.2%) . Among them, there were 13 cases (7.9%) of significant complications, including 2 cases (1.2%) of glenoid fractures during the operation, 4 cases (2.4%) of proximal humeral fractures, 1 case (0.6%) of humeral shaft fractures, and 6 cases (3.6%) of prosthesis dislocation after the operation. Among them, 3 cases underwent revision surgery. It included 2 cases of secondary periprosthetic joint infection. Secondary complications included numbness in fingers or wrists in 8 cases (4.9%) after the operation, pain around the incision in 2 cases (1.2%) after the operation, and poor incision healing in 2 cases (1.2%) after the operation. Among the 13 major complications, nine occurred during the operations of the first 80 cases.
Conclusion These results prove that the complications of reverse shoulder joint replacement surgery are controllable in domestic applications. The core of its successful implementation lies in the solid theoretical foundation of the shoulder joint, strict management of the learning curve, and precise control of technical details, providing an important evidence-based basis for the standardized development of this surgical method in China.